These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28322894)

  • 21. Scientific review and recommendations on preclinical cardiovascular safety evaluation of biologics.
    Vargas HM; Bass AS; Breidenbach A; Feldman HS; Gintant GA; Harmer AR; Heath B; Hoffmann P; Lagrutta A; Leishman D; McMahon N; Mittelstadt S; Polonchuk L; Pugsley MK; Salata JJ; Valentin JP
    J Pharmacol Toxicol Methods; 2008; 58(2):72-6. PubMed ID: 18508287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluation.
    Prior H; Baldrick P; Beken S; Booler H; Bower N; Brooker P; Brown P; Burlinson B; Burns-Naas LA; Casey W; Chapman M; Clarke D; de Haan L; Doehr O; Downes N; Flaherty M; Gellatly N; Moesgaard SG; Harris J; Holbrook M; Hui J; Jones D; Jones K; Kedar H; Mahl A; Manninen A; McGuire A; Mortimer-Cassen E; Peraza M; Pugsley MK; Richard J; Roberts R; Roosen W; Rothfuss A; Schoenmakers A; Sewell F; Weaver R; Weir L; Wolfreys A; Kimber I
    Regul Toxicol Pharmacol; 2020 Jun; 113():104624. PubMed ID: 32126256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro ocular metabolism and bioactivation of ketoconazole in rat, rabbit and human.
    Cirello AL; Dumouchel JL; Gunduz M; Dunne CE; Argikar UA
    Drug Metab Pharmacokinet; 2017 Apr; 32(2):121-126. PubMed ID: 28139372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.
    Short BG
    Toxicol Pathol; 2008 Jan; 36(1):49-62. PubMed ID: 18337221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
    Skov MJ; Beck JC; de Kater AW; Shopp GM
    Int J Toxicol; 2007; 26(5):411-21. PubMed ID: 17963128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonclinical evaluation of immunological safety in Göttingen Minipigs: The CONFIRM initiative.
    Descotes J; Allais L; Ancian P; Pedersen HD; Friry-Santini C; Iglesias A; Rubic-Schneider T; Skaggs H; Vestbjerg P
    Regul Toxicol Pharmacol; 2018 Apr; 94():271-275. PubMed ID: 29481836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host cell proteins induce inflammation and immunogenicity as adjuvants in an integrated analysis of in vivo and in vitro assay systems.
    Yasuno K; Hamamura-Yasuno E; Nishimiya D; Soma M; Imaoka M; Kai K; Mori K
    J Pharmacol Toxicol Methods; 2020; 103():106694. PubMed ID: 32276048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases.
    Brennan FR; Cauvin A; Tibbitts J; Wolfreys A
    Drug Dev Res; 2014 May; 75(3):115-61. PubMed ID: 24782266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E₂-induced ocular inflammation.
    Mathurm M; Gilhotra RM
    Drug Deliv; 2011 Jan; 18(1):54-64. PubMed ID: 20718601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardized electroretinography in primates: a non-invasive preclinical tool for predicting ocular side effects in humans.
    Bee WH
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):81-91. PubMed ID: 11727327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
    Daull P; Paterson CA; Kuppermann BD; Garrigue JS
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolites in safety testing.
    Robison TW; Jacobs A
    Bioanalysis; 2009 Oct; 1(7):1193-200. PubMed ID: 21083045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonclinical pharmacodynamics, pharmacokinetics, and safety of BOL-303224-A, a novel fluoroquinolone antimicrobial agent for topical ophthalmic use.
    Ward KW; Lepage JF; Driot JY
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):243-56. PubMed ID: 17593008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular Therapeutics.
    Gadkar K; Pastuskovas CV; Le Couter JE; Elliott JM; Zhang J; Lee CV; Sanowar S; Fuh G; Kim HS; Lombana TN; Spiess C; Nakamura M; Hass P; Shatz W; Meng YG; Scheer JM
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5390-400. PubMed ID: 26275136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Development of Nonclinical Anti-Drug Antibody Assays to Support Zinpentraxin Alfa Reproductive Toxicology Studies.
    Arjomandi A; Siradze K; Cheu M; Davancaze T; Yadav R; Rao GK; Wong L; Fischer SK
    AAPS J; 2024 Jan; 26(1):16. PubMed ID: 38267613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity testing of therapeutic antibodies in ocular fluids after intravitreal injection.
    Wessels U; Zadak M; Reiser A; Brockhaus J; Ritter M; Abdolzade-Bavil A; Heinrich J; Stubenrauch K
    Bioanalysis; 2018 Jun; 10(11):803-814. PubMed ID: 29637799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of recovery animals in nonclinical safety assessment studies with monoclonal antibodies: further 3Rs opportunities remain.
    Prior H; Andrews L; Cauvin A; Chien H; Clarke DO; Datta K; Dempster M; Dybdal N; Freebern W; de Haan L; Herzyk D; Hey A; Kissner T; Kronenberg S; Leach MW; Lee D; Reid K; Schutte K; Sewell F; Trouba K; Ulrich P; van Aerts L; van Meer P; Weir L
    Regul Toxicol Pharmacol; 2023 Feb; 138():105339. PubMed ID: 36649820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular tissue distribution and pharmacokinetic study of a small 13kDa domain antibody after intravitreal, subconjuctival and eye drop administration in rabbits.
    Gough G; Szapacs M; Shah T; Clements P; Struble C; Wilson R
    Exp Eye Res; 2018 Feb; 167():14-17. PubMed ID: 29074387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
    Buckley LA; Chapman K; Burns-Naas LA; Todd MD; Martin PL; Lansita JA
    Int J Toxicol; 2011 Oct; 30(5):583-90. PubMed ID: 22013138
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.